Antihypoxanth drug Trimetazidine will be supplied also in the package №60

«ALSI Pharma» JSC has registered a new convenient consumer package №60 of the drug Trimetazidine intended to correct conditions caused by vascular and ischemic disorders.


This step is a response to the need of consumers to purchase this form of drug packaging, as this package is designed to receive a month with doctor’s advice to take two tablets per day (the most common dosing regimen of the drug).

The drug has successfully produced by our company since 2009, and is demanded by patients. Very often it is prescribed for the treatment of elderly patients, for whom the therapy with minimal side effects is highly important. We believe that the packaging of 60 tablets per pack would allow consumers to organize the treatment process more conveniently.